Nexalin Technology (NXL) Payables (2021 - 2026)
Nexalin Technology (NXL) posted Payables of $239448.0 for Q2 2026, up 42.44% on a QoQ basis from $168099.0 in Q1 2026, and little changed year-over-year from $240580.0 in Q2 2025.
Analysis
Nexalin Technology (NXL) Payables (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Payables for 6 years, with the latest figure at $239448.0 in Q2 2026.
- On a quarterly basis, Payables changed 0.47% year-over-year to $239448.0 in Q2 2026; TTM through Jun 2026 was $239448.0, a 0.47% change from a year earlier, with the FY2025 full-year figure at $244579.0, up 56.83% from the prior year.
- Payables was $239448.0 for Q2 2026 at Nexalin Technology, up from $168099.0 in the prior quarter.
- The five-year high for Payables was $1.3 million in Q3 2022, with the low at $67493.0 in Q3 2025.
- Average Payables over 5 years is $374045.9, with a median of $210421.0 recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: Payables plunged 86.23% in 2023, then surged 176.09% in 2025.
- Over 5 years, Payables stood at $1.2 million in 2022, then slumped by 86.23% to $159534.0 in 2023, then dropped by 2.25% to $155949.0 in 2024, then soared by 56.83% to $244579.0 in 2025, then dropped by 2.1% to $239448.0 in 2026.
- The last three Payables figures came in at $239448.0 (Q2 2026), $168099.0 (Q1 2026), and $244579.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 5.89 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 277.20 Mn |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn | 2.70 Bn |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn | 2.00 Bn |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn | 1.23 Bn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | 210.50 Mn |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | 968.00 Mn |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn | - |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn | 587.50 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 239,448.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239,448.00 |
| Mar 31, 2026 | 168,099.00 |
| Dec 31, 2025 | 244,579.00 |
| Sep 30, 2025 | 67,493.00 |
| Jun 30, 2025 | 240,580.00 |
| Mar 31, 2025 | 181,394.00 |
| Dec 31, 2024 | 155,949.00 |
| Sep 30, 2024 | 166,542.00 |
| Jun 30, 2024 | 87,138.00 |
| Mar 31, 2024 | 151,510.00 |
| Dec 31, 2023 | 159,534.00 |
| Sep 30, 2023 | 572,549.00 |
| Jun 30, 2023 | 548,501.00 |
| Mar 31, 2023 | 554,758.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.34 Mn |